baber/WOPTO huggingface dataset:
Patent JP-2892505-B2 (JP)
IPC: H05K1/18
Filed: 1995-11-13
Granted: 1999-05-17
Abstract: Resilient contact structures extend from a top surface of a support substrate and solder-ball (or other suitable) contact structures are disposed on a bottom surface of the support substrate. Interconnection elements (110) are used as the resilient contact structures and are disposed atop the support substrate. Selected ones of the resilient contact structures atop the support substrate are connected, via the support substrate, to corresponding ones of the contact structures on the bottom surface of the support substrate. In an embodiment intended to receive an LGA-type semiconductor package (304), pressure contact is made between the resilient contact structures and external connection points of the semiconductor package with a contact force which is generally normal to the top surface of the support substrate (302). In an embodiment intended to receive a BGA-type semiconductor package (404), pressure contact is made between the resilient contact structures and external connection points of the semiconductor package with a contact force which is generally parallel to the top surface of the support substrate (402).
Patent JP-2592774-B2 (JP)
IPC: C07D249/12
Filed: 1993-04-29
Granted: 1997-03-19
Abstract: A process for the production of aryl triazolinones of the formula <IMAGE>  wherein R is lower alkyl; X is independently halogen, lower alkyl, nitro, hydroxy, NHSO2R', -N(SO2R')2, -N(R'(SO2R' where R' is lower alkyl, and n is an integer from 0 to 3; which comprises treating, in a tert-butanol medium, an aryl hydrazine of the formula <IMAGE>  sequentially with (i) a C1-C3 aldehyde, (ii) a cyanate and weak organic acid, and (iii) a hypochlorite, a salt thereof, or a halogen.
Patent JP-3897360-B2 (JP)
IPC: C07D295/108
Filed: 1996-01-23
Granted: 2007-03-22
Abstract: A medicine having the following basic structure, for the alleviation or treatment of symptoms derived from ischemic diseases and seizures, epilepsy, and migraine, having a powerful action in suppressing cytotoxic Ca<2+> overload and free from side-effects: <CHEM> wherein Z = C, CH, or N, X = O or CH2, E and Y = H, OH, a halogen, alkoxy, alkyl, or a halogen-substituted alkyl.
Patent JP-3320419-B2 (JP)
IPC: B23C5/10
Filed: 1996-02-05
Granted: 2002-09-03
Abstract: An insert for use in a ball nose end mill is provided that includes an insert body having a top wall, a bottom wall, and at least one arcuate side wall. An arcuate cutting edge is defined at an intersection between the top and side walls that includes a plurality of sinusoidal undulations for reducing cutting forces, and vibration, and enhancing the breaking and removal of chips removed from a workpiece during a cutting operation. An end portion of the insert crosses the axis of rotation when the insert is mounted in the seat of an end mill body, and the undulations reduce the considerable shear forces applied to the cutting edge at this location. The cutting edge has a profile which follows the contour of a sphere to permit machining a rounded cut. The side wall of the insert body includes an upper relief portion disposed directly under the cutting edge, with a relief angle for preventing the undulations from making unwanted striations or tool marks in the sidewalls of the rounded cut.
Patent JP-3776121-B2 (JP)
IPC: C12Q1/6841
Filed: 1995-05-09
Granted: 2006-05-17
Abstract: In accordance with the present invention, high resolution, rapid and reproducible chromosomal banding methods have been developed. Invention methods enable the accurate mapping of genes to single chromosome bands with no registration shift. In accordance with another embodiment of the present invention, DNA or cDNA probes uniquely identifying physical genomic locations are provided. Such reagents are useful for the identification of the chromosomal band from which a particular DNA sequence is derived.
Patent JP-3805792-B2 (JP)
IPC: C12N15/10
Filed: 1997-03-12
Granted: 2006-08-09
Abstract: A method of identifying antigens which are capable of being endogenously processed by a cellular secretory pathway comprising: introducing an antigen into a donor cell lacking in MHC class I molecules, incubating in an in vitro medium the donor cells, primed cytotoxic T lymphocytes having specificity for the antigen, and target cells which express MHC class I molecules and are labelled with a detectable intracellular marker, under suitable conditions such that the donor cells remain intact, and measuring the amount of detectable marker released into the incubation medium. A method of assaying a medium for the presence of a substance that affects processing of an endogenously processed antigen in a cellular secretory pathway, and; a method of characterizing a tumor or viral antigen capable of being endogenously processed by a cellular secretory pathway.
Patent ES-2363975-B2 (ES)
Title: Uso de la yesotoxina. an�?logos y derivados para el tratamiento y/o la prevención de enfermedades neurodegenerativas relacionadas con tau y beta-amiloide.
Inventor: BOTANA LOPEZ LUIS MIGUEL
IPC: A61K31/352
Filed: 2010-02-08
Granted: 2012-03-21
Abstract: Uso de la yesotoxina, análogos y derivados para el tratamiento y/o la prevención de enfermedades neurodegenerativas relacionadas con tau y {be}-amiloide.#La presente invención se encuentra dentro del campo de la biomedicina y de la química farmaceútica. Específicamente, se refiere al uso la yesotoxina, sus derivados y análogos para la elaboración de un medicamento para la prevención y/o el tratamiento de enfermedades neurodegenerativas relacionados con niveles anormales de proteínas tau y {be}-amiloide, como por ejemplo la enfermedad de Alzheimer.
Patent AU-2001233242-B2 (AU)
Title: Tosylproline analogs as thymidylate synthase inhibitors
Inventor: ERLANSON DANIEL A
IPC: A61P31/10
Filed: 2001-02-02
Granted: 2004-11-18
Abstract: Tosylproline analogs of formula I, methods of making them, pharmaceutical compositions containing them, and methods for their use. The compounds are thymidylate synthase inhibitors; and are useful as anti-tumor agents and as anti-parasitics, anti-bacterials, anti-fungals, and anti-virals.
Patent AU-2001280574-B2 (AU)
Title: Antimicrobial composition useful for the treatment of bovine mastitis
Inventor: STAUB RICHARD K
IPC: A61K33/40
Filed: 2001-07-17
Granted: 2005-05-26
Abstract: The present invention relates to a two-part antimicrobial composition comprising at least one chlorine dioxide generating component comprising at least one metal chlorite and at least one acid-forming compound in a solid carrier, and at least one liquid aqueous component. The composition further comprises at least one antimicrobial fatty acid having from about 2 to about 15 carbon atoms, and preferably from about 6 to about 12 carbon atoms. The components, upon mixing, form a composition having a pH in the range of about 5 to about 10.
Patent AU-2001289195-B2 (AU)
Title: Multiple chamber condiment grinder
Inventor: RYDING PETER A
IPC: A47J42/42
Filed: 2001-09-05
Granted: 2006-08-10
Abstract: The invention concerns a dual chamber condiment grinder having first and second chambers that are spaced and separate from each other, each chamber holding a condiment to be ground, each having a top wall and a bottom wall, means in each chamber for grinding the condiment in the chamber, a handle (76) attached to the top of the chambers, said handle being operable to selectively actuate the means for grinding the condiment in one or the other of the first and second chambers, whereby said handle is including a pivotable member having a cam (70) engageable with a top region of a rasp and said handle being rotatable to selectively position the cam over one or the other of the tops of the rasp. Said cam is selectively movable within the handle.
Patent AU-2002250403-B2 (AU)
Title: Intervertebral space implant for use in spinal fusion procedures
Inventor: SCHNEIDERMAN GARY A
IPC: A61F2/02
Filed: 2002-03-22
Granted: 2006-09-14
Abstract: An implant assembly is provided for surgical implantation into an intervertebral space, such as for stabilization of vertebrae adjacent the intervertebral space during a spinal fusion procedure. The implant assembly includes a primary segment separate from a secondary segment. These segments are elongate and of sufficiently small cross-section that they can be implanted posteriorly in a minimally invasive manner. The primary segment preferably includes a tunnel and the secondary segment preferably includes a neck with the tunnel and neck sized complementally so that the segments stabilize each other where they intersect with the neck within the tunnel. The entire implant assembly is thus provided which both widens and supports the intervertebral space and is sufficiently rigid to provide adequate support for the intervertebral space as the vertebrae are fusing together.
Patent AU-2002324328-B2 (AU)
Title: Use of long pentraxin PTX3 for treating female infertility
Inventor: MANTOVANI ALBERTO
IPC: G01N33/74
Filed: 2002-07-18
Granted: 2007-09-06
Abstract: The PTX3 gene or equivalent PTX3 activity is required for female fertility. Manipulation of PTX3 activity will regulate female fertility. The effects of female sterility may be ameliorated, reproductive ability may be increased or decreased as desired, female fertility may be enhanced, or combinations thereof. The need for therapies that affect female fertility is thereby addressed.
Patent AU-2002327950-B2 (AU)
Title: Sorting sticks for lollipops
Inventor: HALL RUSSELL KEVIN
IPC: A23G9/26
Filed: 2002-09-24
Granted: 2007-06-28
Abstract: An assembly and method for distributing lollipop sticks (9) from a common supply (5) to a plurality of stick holders (14), the assembly comprising an elongated conveyor chamber (3) for containing lollipop sticks as they are conveyed from the common supply to the stick holders, a plurality of stick holding channels, (14) spaced apart and leading from the base of the chamber, the conveyor chamber containing basal surfaces (11), (13) operative to move in each of two substantially opposite directions, and in use the base supporting a plurality of lollipop sticks, the basal surfaces comprising a first basal surface portion (11) and a second basal surface portion (13), the first basal surface portion (11) being obstructive to sticks in contact with the first basal surface portion as said first basal surface portion moves in a first direction away from the common supply (5), and the second basal surface portion (13) being relatively less obstructive to sticks in contact with said second basal surface portion (13) when said second basal surface portion is moved in a second direction towards the common supply, the arrangement of the assembly being such that the basal surface portions are alternately moved in the first and second directions and sticks in contact with the first basal surface portion (11) are displaced in the first direction. Advantageously, the sticks are displaced predominantly in one direction, the first direction, in a common hopper so as to feed a plurality of lollipop stick holders positioned at spaced positions along the hopper base.
Patent AU-2003247628-B2 (AU)
Title: Golf bag with detachable wheel assembly
Inventor: CHELDIN ERWIN
IPC: A63B55/57
Filed: 2003-06-23
Granted: 2009-07-30
Abstract: A golf bag includes a base having a shaft. A pair of wheel assemblies are attachable to, and removable from the shaft. Each wheel assembly includes a wheel and an axle that fits within the shaft such that each wheel is extendable away from, and retractable towards, the base along a common axis. In another embodiment, a golf bag may be motorized.
Patent AU-2004238495-B2 (AU)
Title: New indole derivatives as factor Xa inhibitors
Inventor: WEHNER VOLKMAR
IPC: C07D475/02
Filed: 2004-05-05
Granted: 2010-07-22
Abstract: The present invention relates to compounds of the formula I, <CHEM> in which R<0> ; R<1> ; R<2> ; R<3> ; R<4> ; R<5> ; R<6> ; R<7> ; Q; V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
Patent AU-2004242851-B2 (AU)
Title: Generation of artificial binding proteins based on ubiquitin proteins
Inventor: FIEDLER ULRIKE
IPC: G01N33/68
Filed: 2004-05-27
Granted: 2011-03-10
Abstract: Proteins (A) of the ubiquitin-like protein superfamily that include at least one amino acid (aa) modification, at least in the surface-exposed region of the protein, so as to impart a binding specificity, for a predetermined binding partner, that is not present in the original protein are new. Proteins (A) of the ubiquitin-like protein superfamily that include at least one amino acid (aa) modification, at least in the surface-exposed region of the protein, so as to impart a binding specificity, for a predetermined binding partner, that is not present in the original protein are new. (A), or derived fragments or fusion proteins, retain the ubiquitin-like folding motif of the original protein, and the surface-exposed region includes at least one beta -fold region, optionally also a non-beta -fold region. An independent claim is also included for a method for preparing (A). ACTIVITY : Cytostatic. No biological data given. MECHANISM OF ACTION : Receptor or ligand blockade; targeted delivery of other effectors.
Patent AU-2004283628-B2 (AU)
Title: Immunemodulating oligosaccharides
Inventor: GARSSEN JOHAN
IPC: A23L33/00
Filed: 2004-10-25
Granted: 2010-07-22
Abstract: The present invention relates to a method for enhancing the immune system and the treatment and/or prevention of immune system related disorders in a mammal, particularly newborns, said method comprising the administration of acid oligosaccharide and neutral oligosaccharide. Food compositions suitable for use in the above method are also provided.
Patent AU-2004291919-B2 (AU)
Title: Rapid sample analysis and storage devices and methods of use
Inventor: DAI JIELIN
IPC: G01N31/22
Filed: 2004-11-15
Granted: 2009-12-03
Abstract: The present invention is directed to devices and methods for determining the presence of analyte in a fluid sample. The devices utilize a sample collection well, an expression plate for expressing sample into the sample collection well, a plunger that drives a lance, and a test compartment containing test elements. The devices also preserve an aliquot of fluid sample in a reservoir for later confirmation testing. When the plunger is lowered into the sample collection well, a lance on the device punctures a frangible material that covers a sample outlet. When the sample outlet is thus opened, fluid sample flows from the sample collection cup to the test compartment. In one embodiment the plunger is lowered as a cap is applied to the device. The devices are useful for detecting the presence of analyte in a wide variety of fluid samples, such as saliva, oral fluids, and more. The invention also provides methods of using the devices, and kits containing the devices.
Patent AU-2004323839-B2 (AU)
Title: Computer-based payment transaction system and repository
Inventor: ROBERT BLOWER
IPC: G06Q20/00
Filed: 2004-10-08
Granted: 2011-06-30
Abstract: One embodiment of the invention relates, to a method of operating a payment transaction system maintained by a first party who receives an instruction for a first transaction. The instructed first transaction is directed from a second party to a third party, and includes a transaction date on which the payment transaction system is to give effect to the first transaction. The first party stores the transaction instruction into a database, and permits the third party to access those transaction instructions stored in the database that are directed to the third party. The first party then receives a request from the third party to bring forward at least in part the instructed first transaction. In response to the request, the first party re-directs the first transaction at least in part from the third party to the first party. In addition, the first party creates a new instruction for a second transaction in the system. The second transaction is directed from the first party to the third party and has a second transaction date which is prior to the first transaction date.
Patent AU-2005210782-B2 (AU)
Title: Increment charge for fin-stabilized mortar projectile
Inventor: PESONEN VILLE-PEKKA
IPC: F42B30/12
Filed: 2005-02-08
Granted: 2010-11-11
Abstract: The invention relates to an increment charge (4) to be placed around a tail shaft of a fin-stabilized mortar projectile (1), the increment charge (4) having a centrally located space for the tail shaft and a mounting opening in the space for mounting the increment charge (4). On the opposite side of the increment charge (4) there is provided a protrusion that fits into the mounting opening of an adjacent increment charge (4) for locking them in relation to each other.
Patent AU-2005223767-B2 (AU)
Title: Processes and intermediates for the preparation of aspartic acetal caspase inhibitors
Inventor: MINZHANG CHEN
IPC: C07B43/04
Filed: 2005-03-11
Granted: 2011-12-01
Abstract: The invention relates to processes such as that shown in the scheme and compounds useful for producing modified aspartic acid derivatives, such as aspartic acid aldehyde moieties. Aspartic acid derivatives are useful for preparing caspase inhibitors and/or prodrugs thereof.
Patent AU-2005241018-B2 (AU)
Title: High load operation of an industrial roll door
Inventor: SAUVE RAYMOND
IPC: E06B9/62
Filed: 2005-05-02
Granted: 2010-02-18
Abstract: A high load operation industrial roll door, including a flexible door curtain windable about a top roll positioned above a door opening and provided with a drive system. The roll door includes a bottom beam fastened to the door curtain, and a biasing spring, for resisting movement of the door upon application of a load thereon, and a positive stop preventing movement of the biasing means beyond a predetermined point.
Patent AU-2005264453-B2 (AU)
Title: IL-18 receptor antagonist and pharmaceutical composition containing the antagonist
Inventor: ATSUO SEKIYAMA
IPC: A61P25/00
Filed: 2005-07-15
Granted: 2011-07-14
Abstract: It is intended to provide an IL-18 receptor antibody which serves as an IL-18 receptor antagonist and is immunohistochemically usable; and a pharmaceutical composition and a method for preventing and/or treating IL-18-dependent disorders, in particular, skin thickening caused by ultraviolet rays with the use of the above antibody. Namely, an antibody against IL-18 receptor α subunit characterized by being capable of specifically binding to a polypeptide comprising the amino acid sequence represented by SEQ ID NO:1, or an antibody against IL-18 receptor β subunit characterized by being capable of specifically binding to a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2 is constructed.
Patent AU-2005336447-B2 (AU)
Title: Absorbent articles and laminates containing a bonding pattern
Inventor: MORGAN HANSSON
IPC: B32B27/20
Filed: 2005-09-13
Granted: 2011-12-08
Abstract: The invention refers to an absorbent article such as a diaper, a pant diaper, a sanitary napkin, an incontinence guard etc., said article comprising components that are joined together by a bonding pattern. The bonding pattern (11 , 12, 16, 18) has colour- changing properties triggered by heat and/or pressure exerted during the bonding process, said colour-changing properties being either irreversible or reversible. The colour-changing properties may be accomplished by thermochormic pigments, theromchromicfibres and/or pressure-sensitive pigments. The invention further refers to a laminate formed from two or more web material layers joined together by a bonding pattern having colour-changing.
Patent AU-2006220924-B2 (AU)
Title: Wireless powerless switch sensor
Inventor: URMAN ROBERT
IPC: H01H3/00
Filed: 2006-03-01
Granted: 2010-12-02
Abstract: A passenger door open request switch for use in a multi-passenger, mass-transit vehicle. A wireless, powerless switch sensor which includes an RFID reader, a circuit located remotely from the RFID reader that is formed by connecting an RFID antenna with a control/storage element, and a switch. The switch is connected between the antenna and the storage element in such a way as to either enable or disable the antenna. This allows the system to be configured to monitor the status of the switch.
Patent AU-2006287856-B2 (AU)
Title: Universal event/data recorder system
Inventor: JORDAN LAWRENCE B
IPC: H04B7/00
Filed: 2006-08-11
Granted: 2011-12-15
Abstract: A universal event/data recorder system provides a common bridge between various event/data recorders found on mobile assets. The universal event/data recorder system includes an onboard segment that is capable of interfacing with any manufacturer's event/data recorder device. Additionally, the universal event/data recorder system also includes a remote segment for accessing, analyzing and reviewing data collected from any of a plurality of event/data recorders. The universal event/data recorder system may allow accessing data from various event/data recorders using any of a number of communication means including the Internet and a wireless communication network.
Patent AU-2006313574-B2 (AU)
Title: Bed control procedure
Inventor: HOLLYOAK STEPHEN
IPC: A61G7/012
Filed: 2006-11-07
Granted: 2012-03-29
Abstract: A bed assembly (10) includes a wheeled base (12), a sub-frame (16) and mattress support frame (18). The sub-frame (16) supports a plurality of electrically operated actuators which provide for raising and lowering of the bed (10). The bed can be lowered to a first low position in which the bed frame (18) is around 38 to 45 centimetres above floor height and to a lower position in which the frame (18) is around 30 centimetres above floor height. The bed is lowered to the first height upon receipt of a first command input and can only be lowered below that first height upon receipt of a second control input distinct from the first control input. Preferably, the bed is lowered at a slower speed from the first low height to its lowermost position.
Patent AU-2006337562-B2 (AU)
Title: Multi-band transducer for multi-band feed horn
Inventor: SANDERS PHILIP
IPC: H01P1/161
Filed: 2006-01-31
Granted: 2010-09-30
Abstract: A multi-band transducer is described incorporating a coaxial waveguide interface for use with a multi-band feed and incorporating bent shaped probes yielding all-planar interfaces in microstrip for all frequency ranges and suitable for mass production. Hybrids can be incorporated for linear or circular polarization applications.